This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65391421
rdf:type
wikibase:Item
schema:description
клінічне випробування ensayu clínicu clinical trial klinisch onderzoek
rdfs:label
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
skos:prefLabel
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
schema:name
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
p:P1476
wds:Q65391421-F87DB204-923B-48C1-9F97-39E4220B7996
wdt:P1476
A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
p:P582
wds:Q65391421-11A09735-DB2D-40DD-8650-F377F76E9CA1
wdt:P582
2009-04-01T00:00:00Z
p:P31
wds:Q65391421-E0EB9317-AD60-4664-BC2D-DF7D22D1D9C0
wdt:P31
wd:Q30612
p:P580
wds:Q65391421-5F15688F-D065-425B-BD32-3E3047578594
wdt:P580
2007-06-01T00:00:00Z
p:P17
wds:Q65391421-D802938A-094C-48AC-A4EF-5FCB4DED6F4D
wdt:P17
wd:Q30
p:P6153
wds:Q65391421-B42B9613-1280-469A-A18D-AF0E2AF95A64 wds:Q65391421-BA41F123-002C-44C6-97E9-6B75C2361C2A wds:Q65391421-019F9478-2D2D-4110-B5E6-0C20325CE702 wds:Q65391421-1D3FE9B5-DC50-4F38-A217-CEA930E05F99 wds:Q65391421-3B6A2300-586E-482D-A7F0-474AC7206241 wds:Q65391421-4CF1F14B-C846-4538-9FC4-5A5DE3876FD9 wds:Q65391421-5DCDE7FF-8E37-40FB-9206-E07EE261F929 wds:Q65391421-C4144045-477A-4786-BF11-4E686E91C843 wds:Q65391421-E8F4F701-2D97-4D36-88ED-29D84CC9B514 wds:Q65391421-5DEC009F-D7DC-43B4-A128-E59573213166 wds:Q65391421-619BA156-45E4-41FF-893C-734038B4C173 wds:Q65391421-77E64D71-B14F-410F-959E-73367D30B320
wdt:P6153
wd:Q30269543 wd:Q30269547 wd:Q770544 wd:Q87932226 wd:Q14716149 wd:Q30280592 wd:Q30281210 wd:Q777403 wd:Q61673570 wd:Q6936903 wd:Q30280192 wd:Q7370121
p:P4844
wds:Q65391421-CA33735A-5CCC-41E1-BC6B-78F894E32B59
wdt:P4844
wd:Q415588
p:P2899
wds:Q65391421-871150D7-2D05-406A-9BD7-B84E08F8F879
wdt:P2899
18
p:P1132
wds:Q65391421-D63BE1C0-B1FF-42E5-8425-F05590FE3FC7
wdt:P1132
101
p:P8363
wds:Q65391421-B34E80D9-2292-4873-9A79-529C8EC21087
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65391421-C69FDF66-53C4-4F03-AA78-624973D77241
wdt:P3098
NCT00326599
p:P6099
wds:Q65391421-FDC515BF-4032-4EBA-B3DA-9714712EF30F
wdt:P6099
wd:Q42824440